dbo:abstract
|
- Bentiromide is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. Bentiromide is not available in the United States or Canada; it was withdrawn in the US in October 1996. (en)
|
dbo:alternativeName
|
- N-benzoyl-L-tyrosyl-p-aminobenzoic acid (en)
- Benzoyltyrosyl-p-aminobenzoic acid (Btpaba)Chymex (en)
- Chymex (trade name) (en)
- P-((N-benzoyl-L-tyrosin)amido)benzoic acid (en)
- (S)-p-(α-benzamido-p-hydroxyhydrocinnamamido) benzoic acid (en)
- (S)-4-((2-(benzoylamino)-3-(4-hydroxyphenyl) -1-oxopropyl)amino)benzoic acid (en)
|
dbo:iupacName
|
- 4-[(2S)-2-Benzamido-3-(4-hydroxyphenyl)propanamido]benzoic acid (en)
|
dbo:thumbnail
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 4821 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:imagefile
| |
dbp:imagesize
| |
dbp:othernames
|
- -4 (xsd:integer)
- -p- benzoic acid (en)
- Benzoyltyrosyl-p-aminobenzoic acid Chymex (en)
- Chymex (en)
- N-benzoyl-L-tyrosyl-p-aminobenzoic acid (en)
- P-benzoic acid (en)
|
dbp:pin
| |
dbp:verifiedfields
| |
dbp:verifiedrevid
| |
dbp:watchedfields
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
gold:hypernym
| |
rdf:type
| |
rdfs:comment
|
- Bentiromide is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. Bentiromide is not available in the United States or Canada; it was withdrawn in the US in October 1996. (en)
|
rdfs:label
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |